DPP4 and cancer: In this study, we examined the significance of the nuclear localization of CD26 in its role as a mAb therapy for CD26-positive cancers, and showed that nuclear translocation of CD26 induced by YS110 treatment reduces cell growth through transcriptional repression of the POLR2A gene.